'Alkeran'
Trademark details
'Alkeran'® is a registered trademark used for Medicinal Preparation For the Treatment of Neoplastic Diseases and owned by Smithkline Beecham Corporation, Burroughs Wellcome & Co. (U.S.a.) Inc.. Full trade mark registration details, registered images and more information below.
| Goods and/or Services: | Medicinal Preparation For the Treatment of Neoplastic Diseases |
| Serial Number: | 72044689 |
| Registration Number: | 0681707 |
| Filing Date: | Jan 27, 1958 |
|
Last Applicant(s)/ Owner(s) of Record | Smithkline Beecham Corporation200 North 16th Street |
| Related Products: | Pharmaceuticals |
Suppliers
Total : 1 View more »
Smithkline Beecham Corporation in Atlanta, Georgia, USA
Edit this Company edit this company Smithkline Beecham Corporation 3003 Summit Blvd Ste 1400 Atlanta, Georgia 30319-1477 USA tel: +1 4044605334 Description Mfg Pharmaceutical...
News and Blogs
Total : 6 View more »
Ligand Pharmaceuticals Inc Presents Full Data from
...melphalan (sold by GlaxoSmithKline as Alkeran®for Injection) for multiple...PG-free Melphalan was bioequivalent to Alkeran per guidance requirements, while also...utilize a dosing regimen comparable to Alkeran. The Pivotal study is designed to...
CyDex Receives FDA Acceptance For IND Application For Oncology Drug - Pharmaceutical Business
...chemotherapy for multiple myeloma marketed under the brand name - Alkeran by GlaxoSmithKline. Reportedly, the upcoming...CyDex’s CDX-353: Propylene Glycol-Free Melphalan HCL with Alkeran, and evaluate safety parameters. ...
Celgene Corporation Q2 2009 Earnings Call Transcript -- Seeking Alpha
...agreement with GlaxoSmithKline related to sales of ALKERAN. If I exclude ALKERAN, non-GAAP total revenue increased 14...versus the same period in 2009. Again, if I exclude ALKERAN, non-GAAP total revenue would have increased...
News: GSK Extends Alliance with Aspen in Emerging Markets.
...ranging alliance between the firms to combine commercial activities in Sub-Saharan Africa. The products to be divested are Alkeran for myeloma (excluding U.S.), Kemadrin for Parkinson’s, antibiotic Septrin, Trandate for hypertension...
